Metraipolis › archive › dc_73e265049bfa

Long-Acting Therapeutics in Pediatric Health: Bridging Innovation and Access — Europe PMC PMID:42663383

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42663383
DOI
10.1002/cpt.70458
License (as archived)
solo-consultazione
Archived
2026-10-16T05:08:54.890Z
SHA-256 of the archived text
474defd05a1f8a328164dfbd0beb9c567d98eb4ccdc5c08b58f48ac6e7bc82ed
Stable URL of this page
https://metraipolis.com/documento/dc_73e265049bfa

How to cite

Long-Acting Therapeutics in Pediatric Health: Bridging Innovation and Access — Europe PMC PMID:42663383 — Europe PMC (en), https://europepmc.org/article/MED/42663383 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_73e265049bfa (Metraipolis archive dc_73e265049bfa, sha256 474defd05a1f8a328164dfbd0beb9c567d98eb4ccdc5c08b58f48ac6e7bc82ed)
BibTeX
@misc{dc73e265049bfa,
  title = {Long-Acting Therapeutics in Pediatric Health: Bridging Innovation and Access — Europe PMC PMID:42663383},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42663383},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_73e265049bfa; sha256 474defd05a1f8a328164dfbd0beb9c567d98eb4ccdc5c08b58f48ac6e7bc82ed},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42663383. Agents can read the archived copy with the MCP tool read_document.